64799-08-2

Upstream product

• 109-94-4 formic acid ethyl ester 
• 502-42-1 cycloheptanone 
• 638-49-3 n-pentyl formate 

Downstream Products

• 18202-04-5 2-Diazacycloheptan-1-one 
• 83939-42-8 2-(4-Benzyl-piperazin-1-yl)-6,7,8,9-tetrahydro-5H-cycloheptapyrimidine 
• 14192-58-6 2-[(2-phenylhydrazino)methylidene]cycloheptanone 
• 1225465-13-3 C₂₀H₂₄O₅ 
• 7257-25-2 7,8,9,10-tetrahydrocyclohepta[b]indol-6(5H)-one 
• 187656-11-7 N-Benzyl-N-[2-oxo-cyclohept-(E)-ylidenemethyl]-benzamide 
• 1025134-22-8 2-[1-Benzylamino-meth-(E)-ylidene]-cycloheptanone 
• 7391-45-9 2-oxocycloheptanecarbonitrile 
• 7096-10-8 5,6,7,8-tetrahydro-4H-cyclohept[c]isoxazole 
• 2719-26-8 N-phenylcyclohexanamide 

Relevant academic research and scientific papers

REGIOSPECIFIC SYNTHESIS OF α-(PHENYLTHIO)CYCLOALKENONES AND OF α-PHENYL-α-(PHENYLTHIO)KETONES VIA αα-ADDITION OF PHENYLSULPHENYL CHLORIDE TO α-DIAZOKETONES

Cyclic α-diazoketones react with phenylsulphenyl chloride at room temperature to furnish α-chloro-α-(phenylthio)cycloalkanones which undergo ready dehydrochlorination to α-(phenylthio)cycloalkenones when treated with triethylamine; acyclic, terminal α-diazoketones also furnish α-chloro-α-(phenylthio)adducts which are useful electrophiles in the synthesis of α-phenyl-α-(phenylthio)ketones.

Synthetic Studies toward the Berkeleyacetal Core Architecture

Berkeleyacetals are structurally complex natural products that have shown potent anti-inflammatory activity. The presence of a highly dense oxygen functionality and a polycyclic ring system presents significant synthetic challenges. Herein, we report an e

CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME

The present invention relates to a medicine, particularly a medicine comprising a novel cyclohepta[b]pyridine-3-carbonylguanidine derivative having an inhibitory effect on an Na+/H+ exchanger (NHE). There is provided a cyclohepta[b]p